The World Health Organisation, WHO, Technical Advisory Group on Vaccine Research has recommended a clinical trial in the Democratic Republic of Congo to evaluate the Ervebo vaccine against the Bundibugyo virus. Ervebo is the only licensed vaccine against Ebola.
The WHO is working with partners to begin the trial as soon as possible.
The outbreak continues to spread rapidly across eastern DRC. Total cases have now surpassed 4,000, with 1,850 deaths reported.
More than 300 children have died from Ebola since the outbreak began in the Democratic Republic of Congo, according to figures cited Friday, by the United Nations deputy spokesperson Farhan Haq.
The outbreak is also severely disrupting access to essential healthcare. In the hardest-hit areas, use of health services has dropped by more than 40 percent in recent months, as fear of infection keeps people away.
READ ALSO: DR Congo Intensifies Response to Ebola Outbreak
The situation is also affecting pregnant women. According to the UN Population Fund, maternal deaths in Ituri have nearly doubled since the outbreak began, with about six women dying each week from childbirth-related complications. Ebola infection during pregnancy remains associated with almost universal fetal loss.
During a visit earlier this week to Ituri province, the epicentre of the outbreak, the WHO called for an urgent scale-up of the community-led response, including stronger early detection and contact follow up, as well as better access to care.
To counter fear and misinformation, 13,000 community workers have been deployed by the Ministry of Public Health, WHO, Africa Centres for Disease Control, UNICEF, and partners. They have reached more than 2.4 million people with information on Ebola prevention and early detection and carried out more than 500,000 household visits.
Africanews/Shakirat Sadiq
